BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3893081)

  • 1. Role of isosorbide dinitrate in management of chronic congestive heart failure.
    Parmley WW
    Am Heart J; 1985 Jul; 110(1 Pt 2):264-8. PubMed ID: 3893081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
    Cohn JN; Johnson G; Ziesche S; Cobb F; Francis G; Tristani F; Smith R; Dunkman WB; Loeb H; Wong M
    N Engl J Med; 1991 Aug; 325(5):303-10. PubMed ID: 2057035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of nitrates in congestive heart failure.
    Cohn JN
    Am J Cardiol; 1987 Nov; 60(15):39H-43H. PubMed ID: 3120564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.
    Franciosa JA; Cohn JN
    Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
    Massie BM; Kramer B; Shen E; Haughom F
    Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.
    Leier CB; Magorien RD; Desch CE; Thompson MJ; Unverferth DV
    Circulation; 1981 Jan; 63(1):102-9. PubMed ID: 7438384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination vasodilator therapy for severe chronic congestive heart failure.
    Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B
    Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
    Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
    Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
    Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
    Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
    Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory long-term vasodilator therapy for chronic refractory heart failure: hemodynamic evaluation and clinical response.
    Saito S; Ichikawa M; Ozawa Y; Yumikura S; Nagasawa M; Hibiya K; Tamura Y; Tomobe K; Hatano M
    Jpn Circ J; 1984 Apr; 48(4):350-6. PubMed ID: 6425526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic effects of oral dihydralazine and sublingual isosorbide dinitrate, alone and in combination in chronic heart failure].
    Page A; Larnaudie B; Pic A; Videau P; Besse P
    Arch Mal Coeur Vaiss; 1979 Dec; 72(12):1367-75. PubMed ID: 120154
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction.
    Nyolczas N; Dékány M; Muk B; Szabó B
    Adv Exp Med Biol; 2018; 1067():31-45. PubMed ID: 29086392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.
    Elkayam U; Bitar F
    Am J Cardiol; 2005 Oct; 96(7B):37i-43i. PubMed ID: 16226934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of isosorbide dinitrate and hydralazine on regional metabolic responses to arm exercise in patients with heart failure.
    Wilson JR; Untereker W; Hirshfeld J
    Am J Cardiol; 1981 Nov; 48(5):934-8. PubMed ID: 7304441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydralazine and isosorbide dinitrate in heart failure: historical perspective, mechanisms, and future directions.
    Cole RT; Kalogeropoulos AP; Georgiopoulou VV; Gheorghiade M; Quyyumi A; Yancy C; Butler J
    Circulation; 2011 May; 123(21):2414-22. PubMed ID: 21632515
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
    Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
    Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.